Eris Lifesciences acquires 51 percent stake in Swiss Parenterals to expand its footprint in sterile injectables financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Eris Lifesciences expands footprint in sterile injectables with acquisition of 51% stake in Swiss Parenterals biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Eris Lifesciences signs agreement to buy 51% in Swiss Parenterals for ₹637 crore thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.